Changer for Caregivers and Patients Alike - Uncover Opportunities for Manufacturers Urinary Bag Market Urinary Bag Market ...

UB researcher Chelsie Armbruster is looking at how the urinary tract defends against infection and how understudied pathogens ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.

Surgery is rarely indicated in cases of refractory detrusor instability. Older therapies, such as denervation, myomectomy, diversion, and rhizotomy, are generally no longer considered acceptable.

KOCHI: His journey has been anything but easy. Life challenged him at every step, throwing seemingly insurmountable obstacles ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

Johnson & Johnson has started the submission of an original New Drug Application with the US Food and Drug Administration ...

CHI Memorial Hospital has added a urinary tract infection clinic to its host of services. The clinic provides comprehensive ...

Keck Medicine of USC is conducting a clinical trial that explores using steam as a potential alternative to surgery or ...

Jan. 14, President Biden awarded nearly 400 scientists and engineers the Presidential Early Career Award for Scientists and ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...